Solving complex immunogenicity challenges

Posted by

Agilex Biolabs

Immunogenicity assessment is a critical safety attribute for biotherapeutics undergoing clinical development. Developing clinically relevant immunogenicity assays is an essential element for providing a route for successful submission. This webinar will discuss some of the challenges faced during the development of immunogenicity methods, as well as present some solutions for resolution of those issues. Our panelists will discuss three different case studies that have been utilized to demonstrate the importance of tailoring the development process to the drug and clinical study requirements. WHAT WILL YOU LEARN? Hear about three unique ADA case studies and challenges associated with the development process. Learn the importance of tailoring assay development process to both the drug and the clinical study requirements. Find out a few tools to assist in tackling drug and target tolerance in ADA assays.